hotspot -WSS

hotspot

author：knowledge 2025-08-19 15:02:12 - browse：1335

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： California wildfire smoke linked to 52,000 early deaths, study says

WSS

Pharma companies must ensure equitable access to obesity drugs

Readout Newsletter: Merck, J&J, and long Covid

Elizabeth Holmes banned from government health programs

Stephen Quake on the Chan Zuckerberg quest to conquer disease

California wildfire smoke linked to 52,000 early deaths, study says

How digital therapeutics firms are pivoting after Pear's bankruptcy

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Biotech venture capitalists face new demands from investors

How to save PrEP access — and even expand it

Lilly's Alzheimer's drug donanemab backed by FDA advisers

New air purifier tech could be key to improving indoor air quality

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Moonlake's readout produced a cash windfall. Risks remain

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Continuity nursing helped my family in our darkest PICU moments

Medical device trials still don't enroll enough women, study finds

explore

STAT Virtual Event: ASCO Recap, Live!

AI generated plenty of interest at JPM but not a lot of trust

AI generated plenty of interest at JPM but not a lot of trust

California wildfire smoke linked to 52,000 early deaths, study says

Medicare Advantage today, explained in one chart

Readout Newsletter: Merck, J&J, and long Covid

knowledge

knowledge

focus

Wikipedia